People · Operator
Named in public records as an officer, director or promoter · active 2009–2009 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Prescient Medical Inc | — | Biotechnology | Series A | $5.2M | $187.1M | 2009 |
Scott C. Durbin at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Scott C. Durbin on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| David P. Hochman | 1 | 3 |
| Marvin L. Woodall | 1 | 3 |
| Richard O Martin | 1 | 3 |
| JOEL S. KANTER | 1 | 3 |
| Ilana Odess | 1 | 2 |
| Kevin Kimberlin | 1 | 2 |
| Michele V. Frank | 1 | 1 |
| James G. Benedict | 1 | 1 |
| Patricia K. Scheller | 1 | 1 |
| James F Brennan | 1 | 1 |
| Louis L. Liebhaber | 1 | 1 |
| Dennis J. Genito | 1 | 1 |
| Kurt Krauss | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.